Clinical Trial Update: Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for fruquintinib in patients with metastatic colorectal cancer refractory to standard chemotherapies in South Korea (FIR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Colon Cancer | Phase 2 | Status: NOT_YET_RECRUITING